文献速递心血管MR

中度主动脉瓣狭窄合并二尖瓣反流的重塑与预后研究

Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis: Assessment of Remodeling and Clinical Outcomes.
PubMed 文献 · JACC Cardiovasc Imaging · 2026-06-11

该研究纳入742例经心脏磁共振评估为中度及以上主动脉瓣狭窄的患者,其中中度狭窄422例,按是否合并中度及以上二尖瓣反流分层。结果显示中度主动脉瓣狭窄合并中度及以上二尖瓣反流患者症状负担高、重构更重、预后更差。共病组心血管死亡或心衰住院风险显著升高,尤其见于低流量亚组。

要点

  • 中度主动脉瓣狭窄合并中度及以上二尖瓣反流为高危亚组,即使单项病变未达干预阈值也应警惕。
  • 低流量(每搏量指数≤35 mL/m²)时共病风险更明显,建议关注流量状态进行危险分层。
  • 心脏磁共振可定量评估双瓣膜病变负荷,有助于识别早期干预潜在获益人群。

核心结论

  • 中度主动脉瓣狭窄合并二尖瓣反流患者构成高危亚组,具有高症状负担、不良心脏重构和较差临床结局。

研究设计与样本

  • 研究共纳入742例经心脏磁共振评估为至少中度主动脉瓣狭窄的患者,其中中度狭窄422例,重度狭窄320例。
  • 研究根据主动脉瓣狭窄严重程度和二尖瓣反流负荷进行分层,分析重构参数、症状及心血管死亡和心衰住院结局。
  • 研究采用多变量Cox模型识别与结局相关的协变量。

关键影像表现/征象

  • 中度主动脉瓣狭窄合并中度及以上二尖瓣反流患者出现更显著的左心室容量指数增大和左心室射血分数降低。
  • 共病组主动脉前向血流减少,提示双瓣膜病变对前向血流动力学产生复合影响。

诊断标准与关键数值

  • 中度主动脉瓣狭窄合并中度及以上二尖瓣反流独立关联心血管死亡或心衰住院,校正后风险比为1.86,95%CI为1.31-2.65,P<0.001。
  • 低流量亚组定义为每搏量指数≤35 mL/m²,该亚组中共病相关风险更为显著;正常流量患者仅显示未达统计学显著性的风险增加趋势。
  • 中度主动脉瓣狭窄合并中度及以上二尖瓣反流患者结局较孤立性重度主动脉瓣狭窄更差,并与符合干预标准的重度主动脉瓣狭窄人群相当。

临床应用与阅片要点

  • 在日常阅片中应重视中度主动脉瓣狭窄患者的二尖瓣反流定性定量评估,合并中度及以上反流时需在报告中单独提示高危状态。
  • 对于每搏量指数≤35 mL/m²的低流量患者,合并二尖瓣反流时预后风险最突出,阅片时应特别关注左心室容量和射血分数变化。
  • 心脏磁共振可同时量化主动脉瓣狭窄程度、二尖瓣反流负荷及左心室重构参数,建议作为这类双瓣膜病变综合评估的手段。

局限性

  • 中位随访时间仅1.8年,观察时间相对较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Patients with moderate aortic stenosis (AS) and concomitant mitral regurgitation (MR) often present with symptoms despite neither lesion individually reaching intervention thresholds. The clinical impact of this dual valvular disease remains a knowledge gap.

OBJECTIVES: The aims of this study were to evaluate the effect of concomitant MR on cardiac remodeling and clinical outcomes in patients with moderate AS using cardiac magnetic resonance (CMR) and to compare with isolated moderate and severe AS.

METHODS: A total of 742 patients with at least moderate AS on CMR (422 with moderate AS, 320 with severe AS) were studied. Patients were stratified by AS severity and MR burden. Remodeling parameters, symptoms, and outcomes, including cardiovascular death and heart failure hospitalization, were analyzed. Multivariable Cox models identified covariates associated with outcomes.

RESULTS: Among 422 patients with moderate AS, 76 had moderate or greater MR. Compared with isolated moderate AS, combined AS and MR was associated with higher symptom burden (80.3% in NYHA functional classes II-IV), more pronounced remodeling (larger indexed left ventricular volumes, lower left ventricular ejection fractions), and reduced aortic forward flow. Over a median 1.8 years, coexisting moderate or greater MR was independently associated with cardiovascular death or heart failure hospitalization (adjusted HR: 1.86; 95% CI: 1.31-2.65; P < 0.001). This risk was more apparent in the low-flow subgroup (stroke volume index ≤35 mL/m2), whereas in normal-flow patients, there was a trend toward increased risk that did not reach statistical significance. Outcomes in moderate AS with moderate or greater MR were worse than in isolated severe AS and comparable with severe AS populations meeting criteria for intervention.

CONCLUSIONS: Patients with moderate AS and MR constitute a high-risk subgroup with high symptom burden, adverse cardiac remodeling, and poor clinical outcomes. Risk appears more pronounced in the setting of reduced forward flow (stroke volume index ≤35 mL/m2). CMR enables the quantitative assessment of dual valvular burden and may improve risk stratification. These findings highlight a therapeutic gap and support studies of earlier intervention in this high-risk subgroup.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Gabr, Xiao, Saeed, et al. Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis: Assessment of Remodeling and Clinical Outcomes. JACC Cardiovasc Imaging. 2026. PMID: 42274428. doi:10.1016/j.jcmg.2026.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。